Related Experiment Video
Updated: Aug 29, 2025
Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
Published on: September 14, 2009
An Impedance Sensor for Pathologically Relevant Detection of In-Stent Restenosis In Vitro
Insights
New sensors using electrical impedance spectroscopy (EIS) can detect early signs of stent re-blocking caused by intimal hyperplasia. This technology aims to provide an early warning system for cardiovascular disease complications.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Medical Device Technology
Background:
- Cardiovascular disease (CVD) is a leading global cause of death, often caused by atherosclerosis and leading to heart attacks and strokes.
- Implantable stents are used to treat blocked arteries, but can become re-blocked by intimal hyperplasia, characterized by smooth muscle cell proliferation.
- Early detection of intimal hyperplasia is crucial for preventing stent complications and improving patient outcomes.
Purpose of the Study:
- To develop and validate a novel sensor system for early detection of intimal hyperplasia within stented arteries.
- To utilize electrical impedance spectroscopy (EIS) to monitor cellular changes indicative of stent re-blocking.
- To create a potential early warning system for clinicians to manage stent-related complications.
Main Methods:
- Fabrication of platinum interdigitated electrodes on silicon sensor wafers.
- Co-culture of varying ratios of mouse smooth muscle cells and endothelial cells on the sensors to mimic in vivo stent environment.
- Characterization of cell impedance trends using detection frequency and calculating 'Peak Cumulative Gradients' (PCG) over time.
Main Results:
- Successful co-culture of smooth muscle cells and endothelial cells on EIS sensors.
- Development and application of PCG metric to differentiate between cell types.
- Demonstrated ability of PCG to successfully discriminate between different cell populations.
Conclusions:
- EIS-based sensors with PCG analysis show promise for detecting intimal hyperplasia.
- This technology can serve as an early warning system for stent re-blocking.
- The developed sensor system has the potential to guide clinical decision-making and reduce stent complications.
Abstract:
Cardiovascular disease (CVD) is the biggest cause of death globally. CVD is caused by atherosclerosis which is the accumulation of fatty deposits, often within the fine arteries of the heart or brain. These blockages reduce blood flow and lead to oxygen starvation (ischemia) which can lead to heart attacks and strokes. To treat blocked arteries an implantable device called a stent re-opens the artery to reinstate blood flow to the organ. The stent itself can become blocked over time by cell growth (intimal hyperplasia) which is characterised by excessive smooth muscle cell proliferation. Sensors based on electrical impedance spectroscopy (EIS) embedded in a stent could detect this re-blocking to allow for early intervention. Using platinum interdigitated electrodes on silicon sensor wafers we were able to co-culture different ratios of mouse smooth muscle cells and mouse endothelial cells on these sensors. This mimics the complex, multicellular environment which a stent is found in vivo when undergoing neo-intimal hyperplasia. Trends in the cell impedances were then characterised using the detection frequency and the gradient of change between populations over time which we termed 'Peak Cumulative Gradients (PCG). PCGs were calculated to successfully discriminate each cell type. This work moves towards a sensor that may help guide clinician's decision-making in a disease that is historically silent and difficult to detect. Clinical Relevance-This moves towards an early warning system for the detection of neo intimal hyperplasia ultimately leading to a reduction in stent complications.
